Adequate Selection of Oropharynx Carcinoma Treatment in the Elderly
Received Date: Apr 10, 2017 / Accepted Date: Apr 16, 2017 / Published Date: Apr 26, 2017
Forty seven percent of patients diagnosed in the US between 1973-2008 were ≥ 65 years old and predicted to be >60% by 2030. However, clinical trials do not usually include patients >70 years, so we do not have experience in this increasing field. We present the case of a 79-year-old patient in whom the treatment decision should be well discussed according to comorbidity, treatment toxicity and survival rates.
Keywords: Cetuximab; Elderly; Geriatric assessment scales; Comorbidities; Fragility
Citation: Beatriz LV (2017) Adequate Selection of Oropharynx Carcinoma Treatment in the Elderly. J Cell Sci Apo 1: 105.
Copyright: ©2017 Beatriz LV. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 535
- [From(publication date): 0-2017 - May 24, 2018]
- Breakdown by view type
- HTML page views: 482
- PDF downloads: 53